Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) FCF Margin (2016 - 2025)

Marimed has reported FCF Margin over the past 13 years, most recently at 8.15% for Q4 2025.

  • Quarterly FCF Margin rose 1193.0% to 8.15% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.81% through Dec 2025, up 290.0% year-over-year, with the annual reading at 4.08% for FY2025, 737.0% up from the prior year.
  • FCF Margin was 8.15% for Q4 2025 at Marimed, up from 3.38% in the prior quarter.
  • Over five years, FCF Margin peaked at 31.85% in Q3 2021 and troughed at 29.03% in Q4 2022.
  • The 5-year median for FCF Margin is 4.14% (2024), against an average of 4.27%.
  • Year-over-year, FCF Margin tumbled -5280bps in 2022 and then soared 4880bps in 2023.
  • A 5-year view of FCF Margin shows it stood at 14.12% in 2021, then crashed by -306bps to 29.03% in 2022, then skyrocketed by 168bps to 19.77% in 2023, then tumbled by -119bps to 3.78% in 2024, then soared by 316bps to 8.15% in 2025.
  • Per Business Quant, the three most recent readings for MRMD's FCF Margin are 8.15% (Q4 2025), 3.38% (Q3 2025), and 3.29% (Q2 2025).